Imatinib for the treatment of refractory, diffuse systemic sclerosis
- PMID: 18326532
- DOI: 10.1093/rheumatology/ken104
Imatinib for the treatment of refractory, diffuse systemic sclerosis
Comment in
-
Paraneoplastic scleroderma secondary to hairy cell leukaemia successfully treated with cladribine.Rheumatology (Oxford). 2008 Nov;47(11):1734-5. doi: 10.1093/rheumatology/ken367. Epub 2008 Sep 23. Rheumatology (Oxford). 2008. PMID: 18812428 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources